Additional information
| Active substance | Tretinoin |
|---|---|
| Water Retention | None |
| Hepatotoxicity | Low risk when used topically |
| Lab Test | Not typically required for monitoring |
| Strength | 0.05% |
| Also known as | Retin-A |
| Blood pressure | No direct effect |
| Trade name | Retin-A, Renova, among others |
| Storage conditions | Store at controlled room temperature, protect from light |
| Chemical name | all-trans retinoic acid |
| Formula | C20H28O2 |
| Substance class | Retinoid |
| Main action | Modulates gene expression to reduce skin inflammation and promote cell turnover |
| Half-life | 0.5 to 2 hours |
| Dosage (medical) | Typically 0.02% to 0.1% creams or gels applied topically once daily at bedtime |
| Dosage (sports) | Not applicable |
| Effects | Accelerates the turnover of superficial skin cells, reduces the formation of acne, and can diminish fine wrinkles |
| Side effects | Skin irritation, redness, dryness, and increased sensitivity to sunlight |
| Use in sports | None |
| Manufacturer | Menarini Pharma |
| Packing | 1 tube/pack |
GLUCOPHAGE Merckgroup
Muscoflex 8 mg Bilim
Norvacs 5 mg Pfizer
Januvia 100mg Merckgroup
Champix 56 tabs Pfizer
Champix Starter Pack Pfizer
Prograf 5mg Astellas Pharma
Rovamycine 3.000.000 iu Eczacibasi
Avory Pharma Deca Durabolin 300mg 10ml
Prograf 1mg Astellas Pharma
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Fostimon (Merional) 150 IU HMG IBSA 

Reviews
There are no reviews yet.